Comparative HPLC and ELISA studies for CDT isoform characterization in subjects with alcohol related problems. Prospective application in workplace risk-prevention policy

Giornale Italiano di Medicina del Lavoro ed Ergonomia

Volumn 30, Issue 2, 2008, Pages 119-127

  Coccini, T ^a   Crevani, A ^b   Acerbi, D ^a   Roda, E ^b   Castoldi, A F ^a   Crespi, V ^c   Manzo, L ^a,b  

^a IRCCS   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Alcoholism; Biomarkers; Workplace

Indexed keywords

CARBOHYDRATE DEFICIENT TRANSFERRIN; CARBOHYDRATE-DEFICIENT TRANSFERRIN; DRUG DERIVATIVE; ISOPROTEIN; TRANSFERRIN;

ALCOHOLISM; ARTICLE; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; OCCUPATIONAL HEALTH; RISK;

ALCOHOL-RELATED DISORDERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; OCCUPATIONAL HEALTH; PROTEIN ISOFORMS; RISK; TRANSFERRIN;

EID: 56649118898     PISSN: 15927830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Stibler H. Carbohydrate-deficient transferrin in serum: a new marker of potentially harmful alcohol consumption reviewed. Clin Chem 1991; 37: 2029-2037.
2. Landberg E, Påhlsson P, Lundblad A, Arnetorp A, Jeppsson J-O. Carbohydrate composition of serum transferrin isoforms from patients with high alcohol consumption. Biochem Biophys Res Commun 1995; 210: 267-274.
3. Peter J, Unverzagt C, Engel WD, Renauer D, Seidel C, Hösel W. Identification of carbohydrate deficient transferrin forms by MALDI-TOF mass spectrometry and lectin ELISA. Biochim Biophys Acta 1998; 1380: 93-101.
4. Helander A, Eriksson G, Stibler H, Jeppsson J-O. Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse. Clin Chem 2001; 47: 1225-1233.
5. Batey RG, Madsen G. The carbohydrate-deficient transferrin test in hospital practice. Drug Alcohol Rev 1998; 17: 105-109.
6. Spies CD, Kissner M, Neumann T, Blum S, Voigt C, Funk T, Runkel N, Pragst F. Elevated carbohydrate-deficient transferrin predicts prolonged intensive care unit stay in traumatized men. Alcohol Alcohol 1998; 33: 661-669.
7. Hermansson U, Helander A, Huss A, Brandt L, Rönnberg S. The Alcohol Use Disorders Identification Test (AUDIT) and carbohydrate-deficient transferrin (CDT) in a routine workplace health examination. Alcohol Clin Exp Res 2000; 24: 180-187.
8. Bortolotti F, De Paoli G, Tagliaro F. Carbohydrate-deficient transferrin (CDT) as a marker of alcohol abuse: A critical review of the literature 2001-2005. J Chromatogr B 2006; 841: 96-109.
9. Kristenson H, Jeppsson J-O. Drunken driver examinations. CD-transferrin is a valuable marker of alcohol consumption. Läkartidningen 1998; 95: 1429-1430.
10. Helander A. Biological markers in alcoholism. J Neural Transm Suppl 2003: 15-32.
11. Hermansson U, Knutsson A, Brandt L, Huss A, Rönnberg S, Helander A. Screening for high-risk and elevated alcohol consumption in day and shift workers by use of the AUDIT and CDT. Occup Med 2003: 53:518-526.
12. Mangione T, Howland J, Lee M. New Perspectives for Worksite Alcohol Strategies: Result from a Corporate Drinking Study. Boston, MA: JSI Research and Training Institute, 1998.
13. Henderson M, Hutcheson G, Davies J. Alcohol and the Workplace. Copenhagen: WHO Regional Publications, 1996; European Series No. 67.
14. Spigno F, Debarbier N, Traversa F. 2007. Lavoro e dipendenza da sostanze psicoattive: idoneità alla mansione e prospettive di prevenzione alia luce delle recenti innovazioni normative. G Ital Med Lav Erg 2007; 29: 158-165.
15. Diagnostic and Statistical Manual of Mental Disorders Fourth Edition (DSM-IV), published by the American Psychiatric Association, Washington D.C., 1994.
16. Mangione TW, Howland J, Amick B, Cote J, Lee M, Bell N, Levine S. Employee drinking practices and work performance. J Stud Alcohol 1999; 60: 261-270.
17. Stibler H. Diagnosis of alcohol-related neurological diseases by analysis of carbohydrate-deficient transferrin in serum. Acta Neurol Scand 1993; 88: 279-283.
18. Meerkerk GJ, Njoo KH, Bongers IM, Trienekens P, van Oers JA. The specificity of the CDT assay in general practice: the influence of common chronic diseases and medication on the serum CDT concentration. Alcohol Clin Exp Res 1998; 22: 908-913.
19. Aldén A, Ohlson S, Påhlsson P, Rydén I. HPLC analysis of carbohydrate deficient transferring isoforms isolated by the Axis-Shield %CDT method. Clin Chim Acta 220; 356: 143-146.
20. Arndt T. Carbohydrate-deficient transferrin as a marker of chronic alcohol abuse: a critical review of preanalysis, analysis, and interpretation. Clin Chem 2001; 47: 13-27.
21. Helander A, Dahl H, Swanson I, Bergström J. Evaluation of Dade Behring N Latex CDT: a novel homogenous immunoassay for carbohydrate-deficient transferrin. Alcohol Clin Exp Res 2004; 28: 33A [Suppl].
22. Helander A, Bergstrom JP. Determination of carbohydrate-deficient transferrin in human serum using the Bio-Rad %CDT by HPLC test. Clin Chim Acta 2006; 371: 187-190.
23. Bergström JP, Helander A. Influence of alcohol use, ethnicity, age, gender, BMI and smoking on the serum transferrin glycoform pattern: Implications for use of carbohydrate-deficient transferrin (CDT) as alcohol biomarker. Clin Chim Acta 2008; 388: 59-67.
24. Hock B, Schwartz M, Domke I, Grunert VP, Wuertenberger M, Schieman U, Horster S, Limmer C, Stecker G, Soyka M. Validity of carbohydrate-deficient transferrin (CDT), γ-glutamyltransgerase (γ-GT) and mean corpuscular erythrocyte volume (MCV) as biomarkers fro chronic alcohol abuse: a study in patients with alcohol dependence and liver disorders of non-alcoholic and alcoholic origin. Addiction 2005; 100: 1477-1486.
25. Mårtensson O, Härlin A, Brandt R, Seppä K, Sillanaukee P. Transferrin isoform distribution: gender and alcohol consumption. Alcohol Clin Exp Res 1997; 21: 1710-1715.
26. Helander A, Husa A, Jeppsson J-O. Improved HPLC Method for Carbohydrate-deficient Transferrin in Serum. Clin Chem 49: 11 1881-1890 (2003)
27. Jeppsson J-O, Arndt T, Schellenberg F, et al. Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method. Clin Chem Lab Med 2007; 45: 558-562.
28. Crespi V, Andreotta U, Tettamanzi E, Ferrarrio MM. Un marcatore biologico per la diagnosi di abuso alcolico: CDT. Med Lav 2007; 98: 466-474.
29. Schwan R, Loiseaux MN, Albuisson E, Legros FJ, Nuyens V, Malet L, et al. Performance of asialotransferrin in detecting alcohol abuse. Alcohol Clin Exp Res 2005; 29: 81-83.
30. Bean P, Sutphin MS, Liu Y, Anton R, Reynolds TB, Shoenfeld Y, et al. Carbohydrate-deficient transferrin and false positive results for alcohol abuse in primary biliary cirrhosis: differential diagnosis by detection of mitochondrial autoantibodies. Clin Chem 1995; 41: 858-861.
31. Perret R, Froehlich F, Lavanchy D, Henry H, Bachman C, Pecoud A, et al. Is carbohydrate-deficient transferrin a specific marker for alcohol abuse? A study in patients with chronic viral hepatitis. Alcohol Clin Exp Res 1997; 21: 1337-1342.
32. Murawaki Y, Sugisaki H, Yuasa I, Kawasaki H. Serum carbohydrate-deficient transferrin in patients with nonalcoholic liver disease and with hepatocellular carcinoma. Clin Chim Acta 1997; 259: 97-108.
33. Arndt T, Hackler R, Muller T, Kleine TO, Gressner AM. Increased serum concentration of carbohydrate-deficient transferrin in patients with combined pancreas and kidney transplantation. Clin Chem 1997; 43: 344-351.
34. De Feo TM, Fargion S, Duca L, Mattioli M, Cappellini MD, Sampietro M, et al. Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology 1999; 29: 658-663.
35. van Pelt J, Azimi H. False-positive CDTect values in patients with low ferritin values. Clin Chem 1998; 44: 2219-2220.
36. Sorvajarvi K, Blake JE, Israel Y, Niemela" O. Sensitivity and specificity of carbohydrate-deficient transferrin as a marker of alcohol abuse are significantly influenced by alterations in serum transferrin: comparison of two methods. Alcohol Clin Exp Res 1996; 20: 449-454.
37. Stauber RE, Jauk B, Fickert P, Hausler M. Increased carbohydrate- deficient transferrin during pregnancy: relation to sex hormones. Alcohol Alcohol 1996; 31: 389-392.
38. La Grange L, Anton RF, Garcia S, Herrbold C. Carbohydrate-deficient transferrin levels in a female population. Alcohol Clin Exp Res 1995; 19: 100-103.
39. Bråthen G, Bjerve KS, Brodtkorb E, Bovim G. Validity of carbohydrate deficient transferrin and other markers as diagnostic aids in the detection of alcohol related seizures. J Neurol Neurosurg Psychiatry 2000; 68: 342-348.
40. Stibler H, Jaeken J, Kristiansson B. Biochemical characteristics and diagnosis of the carbohydrate-deficient glycoprotein syndrome. Acta Paediatr Scand 1991; 375(Suppl): 21-31.
41. Bergström JP, Helander A. HPLC evaluation of clinical and pharmacological factors reported to cause false-positive carbohydrate-deficient transferrin (CDT) levels. Clin Chim Acta 2008; 389: 164-166.
42. Helander A. Absolute or relative measurement of carbohydrate-deficient transferrin in serum? Experiences with three immunological assays. Clin Chem 1999; 45: 131-135.
43. Webb GR, Redman S, Hennrikus DJ, Kelman GR, Gibberd RW, Sanson-Fisher RW. The relationships between high-risk and problem drinking and the occurrence of work injuries and related absences. J Stud Alcohol 1994; 4: 434-446.
44. European Alcohol Action Plan (2000-2005) (WHO Regional Office for Europe, Copenhagen).
45. European Charter on Alcohol (Paris, 1995) (WHO Regional Office for Europe, Copenhagen).
46. WHO. Global Status Report on Alcohol 2004. Department of Mental Health and Substance Abuse, WHO, Geneva.
47. Bordini L, Patrini L, Ricci MG, Verga A, Ribaldi L. Consumo di alcool, idoneità complesse e responsabilità verso terzi: l'esperienza di una coorte di addetti al trasporto pubblico urbano. Med Lav 2007; 98: 501-512.
48. Hannuksela ML, Liisanantti MK, Nissinen AE, Savolainen MJ. Biochemical markers of alcoholism. Clin Chem Lab Med. 2007; 45: 953-961.
49. Coccini T, Castoldi AF, Gandini C, Randine G, Vittadini G, Baiardi P, Manzo L. Platelet monoamine oxidase B activity as a state marker for alcoholism: trend over time during withdrawal and influence of smoking and gender. Alcohol Alcohol 2002; 37: 566-572.
50. Arndt T, Guessregen B, Hallermann D, Nauck M, Weckesser H. Forensic analysis of carbohydrate-deficient transferrin (CDT) by HPLC. Statistics and extreme values. Forensic Sci Int 2008; 175: 27-30.
51. Hietala J, Koivisto H, Anttila P, Niemela O. Comparison of the combined marker GGT-CDT and the conventional laboratory markers of alcohol abuse in heavy drinkers, moderate drinkers and abstainers. Alcohol Alcohol 2006; 41: 528-533.
52. United States Department of Agriculture and United States Department of Health and Human Services. In: Dietary Guidelines for Americans. Accessed on 25 April 2007.